Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-10-004615
Filing Date
2010-12-30
Accepted
2010-12-30 12:41:01
Documents
6
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT andain_10k-123106.htm 10-K 1167549
2 CONSULTING AGREEMENT BETWEEN THE COMPANY AND DR. LEONID LURYA, DATED MAY 16, 200 ex10-2.htm EX-10.2 107638
3 CONSULTING AGREEMENT BETWEEN THE COMPANY AND MEIZAM - ADVANCED ENTERPRISE CENTER ex10-10.htm EX-10.10 67225
4 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF SAM SHLOMO ELIMELECH ex31-1.htm EX-31.1 9844
5 RULE 13A-14(A)/15D-14(A) CERTIFICATION OF GAI MAR-CHAIM ex31-2.htm EX-31.2 9821
6 SECTION 1350 CERTIFICATION OF SAM SHLOMO ELIMELECH AND GAI MAR-CHAIM ex32.htm EX-32 6653
  Complete submission text file 0001437749-10-004615.txt   1370211
Mailing Address 350 S. CENTER STREET SUITE 500 RENO NV 89501
Business Address 350 S. CENTER STREET SUITE 500 RENO NV 89501 775-333-5997
ANDAIN, INC. (Filer) CIK: 0001321502 (see all company filings)

EIN.: 202066406 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51216 | Film No.: 101280266
SIC: 2834 Pharmaceutical Preparations